Fig. 3

Forest plots of the effects of SGLT2i on cardiac function. a LVEF; b GLS; c E/eʹ. SGLT2i sodium–glucose cotransporter 2 inhibitors, T2DM type 2 diabetes mellitus, HF heart failure, LVEF left ventricular ejection fraction, GLS global longitudinal strain, E/eʹ mitral inflow to mitral relaxation velocity ratio